Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11892871 | 0.68 | MAPT (0.33) | — | |
| SCHEMBL17193003 | 0.65 | MAPT (0.32) | — | |
| SCHEMBL18473401 | 0.65 | ALDH1A1 (0.32) | — | |
| SCHEMBL18473398 | 0.65 | MAPT (0.32) | — | |
| SCHEMBL17192994 | 0.65 | ALDH1A1 (0.32) | — | |
| SCHEMBL12712164 | 0.65 | LMNA (0.35) | LMNAMAPK1 | |
| SCHEMBL12737832 | 0.63 | CNR1 (0.38) | MAPK1 | |
| SCHEMBL15281521 | 0.62 | — | — | |
| SCHEMBL20087138 | 0.62 | MAPK14 (0.33) | MAPK14 | |
| SCHEMBL12924203 | 0.61 | MAPK14 (0.38) | MAPK14LMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12193317-B2 | Organic semiconducting compounds | FLEXENABLE TECHNOLOGY LIMITED (GB) | 2025-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12193317-B2 | Organic semiconducting compounds | OCIAD2, OCIAD1, OSTC | MAPK14 2835/4885LMNA 4414/4885MAPK1 2031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.